NCT01317381View on ClinicalTrials.gov

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2010

Study Completion Date

May 31, 2011

Conditions
Critically Ill Patients
Interventions
PROCEDURE

Observational

Blood draw

Trial Locations (1)

Unknown

RECRUITING

Zurich

Sponsors

Collaborators (1)

Intuitive Surgical
All Listed Sponsors
collaborator

Intuitive Surgical

INDUSTRY

lead

University of Zurich

OTHER

NCT01317381 - ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill | Biotech Hunter | Biotech Hunter